Bolstering the FDA's drug-safety authority

N Engl J Med. 2007 Nov 29;357(22):2217-9. doi: 10.1056/NEJMp078212.
No abstract available

MeSH terms

  • Drug Approval / legislation & jurisprudence*
  • Drug Evaluation / legislation & jurisprudence
  • Drug Industry / economics
  • Drug Industry / legislation & jurisprudence
  • Drug Labeling / legislation & jurisprudence*
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Product Surveillance, Postmarketing*
  • United States
  • United States Food and Drug Administration